You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Bulk Pharmaceutical API Sources for mannitol


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for mannitol

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free M1902_SIGMA ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free M4125_SIAL ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free M8429_SIAL ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free M9546_SIAL ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free M9647_SIAL ⤷  Get Started Free
Hangzhou Trylead Chemical Technology ⤷  Get Started Free TL806434 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for Mannitol

Last updated: July 31, 2025

Introduction

Mannitol, a sugar alcohol derived from mannose, is a widely used pharmaceutical excipient and active ingredient, notably in osmotic diuretics, dental applications, and as a carrier in drug formulations. Its pharmaceutical applications demand high-quality, pharmaceutical-grade APIs produced through robust manufacturing processes compliant with international standards such as the United States Pharmacopeia (USP) and European Pharmacopoeia (EP). Identifying reliable, high-quality bulk API sources for mannitol is vital for pharmaceutical companies seeking to ensure supply chain integrity, regulatory compliance, and cost efficiency.

This comprehensive overview examines key global manufacturers and suppliers of pharmaceutical-grade mannitol, emphasizing their production capabilities, quality standards, and market presence.

Manufacturing Countries and Major Suppliers

1. China

China dominates the global mannitol API market, accounting for a significant share due to its extensive manufacturing base and cost competitiveness.

  • Shandong Yuwang Group Co., Ltd.
    Yuwang is among the leading Chinese producers of pharmaceutical excipients, including mannitol. Their API products meet USP and EP standards, with large-scale production facilities capable of satisfying bulk demand across Asia and internationally.

  • Shandong Sanyuan Biotechnology Co., Ltd.
    Specializes in bulk pharmaceutical excipients, providing high-purity crystalline mannitol suitable for medicinal use. They hold GMP certifications and supply to global markets.

  • Jinan Siruba Polymer Material Co., Ltd.
    While primarily focused on polymer materials, they also manufacture pharmaceutical-grade mannitol, emphasizing compliance with international quality standards.

Strengths: Cost advantage, large production capacity, expanding quality compliance, and aggressive export strategies.

2. India

India remains a prominent source of pharmaceutical excipients including mannitol, owing to its established pharmaceutical manufacturing ecosystem and stringent regulatory landscape.

  • Roquette India Pvt. Ltd. (Expansion through partnerships)
    Known globally for excipient manufacturing, Roquette’s Indian operations produce pharmaceutical-grade mannitol, adhering to international standards.

  • Viswaat Chemical Industries Ltd.
    Offers high-quality crystalline mannitol with USP and EP compliance, catering to bulk pharmaceutical demands across Asia, Europe, and North America.

  • VASA Scientific Solutions
    Supplies pharmaceutical-grade mannitol designed for parenteral and oral applications, complying fully with GMP guidelines.

Strengths: Certification accreditations, high-quality product range, and a strong regulatory reputation.

3. Europe

European manufacturers focus heavily on quality, regulatory compliance, and technological innovation, targeting premium pharmaceutical markets.

  • FMC Corporation (Now part of DuPont)
    Produces pharmaceutical-grade mannitol with high purity levels suitable for parenteral and injectable formulations. Their adherences to Good Manufacturing Practices (GMP) and regulatory standards make them a premium supplier.

  • Merck KGaA
    Offers mannitol as part of their pharmaceutical excipient portfolio. Their manufacturing facilities maintain strict adherence to EU standards, with extensive R&D capabilities.

  • Roquette Frères (France)
    A global leader in pharmaceutical excipients with facilities producing USP, EP, and JP-grade mannitol. Their rigorous quality controls and certifications (ISO, GMP) position them as a preferred supplier.

Strengths: Consistent quality, regulatory compliance, and reliable supply chains within Europe.

4. North America

The U.S. and Canada host key pharmaceutical excipient producers focusing on high-purity mannitol suitable for sterile formulations.

  • Dow Chemical Company
    Offers pharmaceutical-grade mannitol with USP and EP standards, primarily used in parenteral applications and dental formulations.

  • Roquette North America
    Their North American operations supply pharmaceutical-grade mannitol, emphasizing strict quality and regulatory adherence.

  • Pfizer Inc.
    While primarily known as a pharmaceutical manufacturer, Pfizer supplies bulk pharmaceutical excipients, including mannitol, sourced through their established supply chains.

Strengths: High regulatory standards, quality assurance, and proximity to major pharmaceutical markets.

Market Dynamics and Supplier Selection Criteria

  • Quality & Compliance: Ensuring suppliers adhere to USP, EP, or JP standards and hold GMP certifications is non-negotiable.
  • Supply Capacity: Long-term supply agreements depend on a manufacturer’s ability to sustain large-volume production.
  • Regulatory Track Record: Suppliers with an established history of compliance streamline regulatory approval processes.
  • Cost-effectiveness: Cost remains a pivotal factor, especially for bulk procurement, though it must be balanced against quality.
  • Geopolitical Stability & Logistics: A supplier’s country stability and logistics infrastructure influence supply chain resilience.

Emerging Trends & Challenges

  • Rising Regulatory Stringency: Increased quality demands from agencies such as the FDA and EMA intensify supplier vetting processes.
  • Supply Chain Disruptions: COVID-19 underscored vulnerabilities, prompting manufacturers to diversify sourcing regions.
  • Sustainability & Green Chemistry: Growing emphasis on environmentally sustainable manufacturing practices influences supplier selection.
  • Technological Innovations: Advanced crystallization and purification processes improve API purity and batch consistency.

Conclusion

Securing a reliable bulk API source for mannitol hinges on balancing quality, supply chain stability, regulatory compliance, and cost. Chinese manufacturers dominate due to capacity and cost advantages, but European and North American suppliers provide premium, high-purity options tailored for sensitive pharmaceutical applications. Indian suppliers represent a middle ground, combining quality with competitive pricing.

Pharmaceutical companies must prioritize partnerships with suppliers demonstrating consistent quality standards, transparent compliance history, and scalable capacity to ensure uninterrupted supply for their formulations.


Key Takeaways

  • Global Suppliers: The primary bulk sources for pharmaceutical-grade mannitol are concentrated in China, India, Europe, and North America, each offering distinct advantages.
  • Quality Assurance: Suppliers adhering to international pharmacopeia standards and GMP regulations are critical for regulatory approval and product safety.
  • Supply Security: Diversification of supply chains mitigates risks associated with geopolitical or logistical disruptions.
  • Market Trends: Sustainability and technological advancements influence future sourcing strategies.
  • Vendor Evaluation: Due diligence focusing on certification, capacity, compliance, and reliability ensures supply chain integrity.

FAQs

1. What criteria should I consider when selecting a mannitol API supplier?
Prioritize suppliers with GMP certification, adherence to USP/EP standards, proven quality control measures, adequate production capacity, and a track record of regulatory compliance.

2. Are Chinese mannitol suppliers reliable for pharmaceutical applications?
Yes. Many Chinese suppliers meet international standards such as USP and EP, with rigorous quality controls, making them suitable for pharmaceutical use. Due diligence and supplier audits are recommended.

3. How does the purity level of mannitol impact its pharmaceutical applications?
Higher purity (e.g., USP or EP grades) ensures safety, minimizes contaminants, and complies with regulatory standards for pharmaceutical and parenteral formulations.

4. What role does regulatory compliance play in sourcing mannitol APIs?
Regulatory compliance ensures market approval, safety, and quality assurance, reducing the risk of product rejection during validation or post-market surveillance.

5. Is there a growing preference for European or North American suppliers over Asian suppliers for mannitol?
While Asian suppliers dominate due to cost advantages, pharmaceutical manufacturers seeking higher regulatory assurance or specialized formulations often prefer European or North American suppliers, especially for sensitive applications like injectables.


Sources:
[1] "Global Pharmaceutical Excipient Market," Industry Reports, 2022.
[2] "Pharmacopeia Standards for Mannitol," USP and EP Monographs.
[3] "Leading Manufacturers of Mannitol," Company Websites and Certification Portfolios.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.